Clinical Trials Directory

Trials / Sponsors / Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc.

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingEXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety
Alport Syndrome, X-Linked, Alport Syndrome, Autosomal Recessive
Phase 22026-05-30
CompletedA Study of ELX-02 in Patients With Alport Syndrome
Alport Syndrome
Phase 22022-11-28
CompletedA Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G54
Cystic Fibrosis
Phase 22019-11-25
CompletedA Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G5
Cystic Fibrosis
Phase 22019-11-05
TerminatedA Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis
Genetic Disease, Nonsense Mutation, Cystinosis
Phase 22019-08-02
CompletedA Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02
Impaired Renal Function
Phase 12019-01-04
CompletedPhase 1 Study of ELX-02 in Healthy Adult Subjects
Genetic Disease, Nonsense Mutation
Phase 12017-10-11
CompletedPhase 1 Study of ELX-02 in Healthy Adults
Genetic Disease, Nonsense Mutation
Phase 12017-09-26
TerminatedSafety, Tolerability, Pharmacokinetics of ELX-02 in Healthy Adult Volunteers
Genetic Diseases, Nonsense Mutations
Phase 12016-07-01